Cargando…
The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
Background: The recombinant IL-1 receptor antagonist anakinra—currently approved for the treatment of autoinflammatory diseases—blocks IL-1β-mediated inflammatory signaling. As inflammation is a major driver of cancer, we hypothesized that anakinra might be able to mitigate glioblastoma (GBM) aggres...
Autores principales: | Hübner, Max, Effinger, David, Wu, Tingting, Strauß, Gabriele, Pogoda, Kristin, Kreth, Friedrich-Wilhelm, Kreth, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072290/ https://www.ncbi.nlm.nih.gov/pubmed/32069807 http://dx.doi.org/10.3390/cancers12020433 |
Ejemplares similares
-
MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
por: Hübner, Max, et al.
Publicado: (2020) -
Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4
por: Hübner, Max, et al.
Publicado: (2018) -
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
por: Thon, Niklas, et al.
Publicado: (2013) -
Cell-Crossing Functional Network Driven by microRNA-125a Regulates Endothelial Permeability and Monocyte Trafficking in Acute Inflammation
por: Müller, Martin Bernhard, et al.
Publicado: (2022) -
Very‐low‐carbohydrate diet enhances human T‐cell immunity through immunometabolic reprogramming
por: Hirschberger, Simon, et al.
Publicado: (2021)